n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Endometrial Neoplasms in 3 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
Endometrial Neoplasms: Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.
Excerpt | Relevance | Reference |
---|---|---|
"(4) NS-398 could restrain endometrial cancer cells invasion." | 1.35 | Proteomics reveals protein profile changes in cyclooxygenase-2 inhibitor-treated endometrial cancer cells. ( Jingting, C; Yi, Z; Yu, Z, 2009) |
"In human endometrial cancer, the fourth most common cancer in women, tumor suppressor phosphatase tensin homologue (PTEN) is frequently mutated." | 1.32 | Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells. ( Asselin, E; Gagnon, V; Mathieu, I; Parent, S; St-Germain, ME, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yi, Z | 1 |
Jingting, C | 1 |
Yu, Z | 1 |
St-Germain, ME | 1 |
Gagnon, V | 1 |
Mathieu, I | 1 |
Parent, S | 1 |
Asselin, E | 1 |
Gao, J | 1 |
Niwa, K | 1 |
Takemura, M | 1 |
Sun, W | 1 |
Onogi, K | 1 |
Wu, Y | 1 |
Seishima, M | 1 |
Mori, H | 1 |
Tamaya, T | 1 |
3 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Endometrial Neoplasms
Article | Year |
---|---|
Proteomics reveals protein profile changes in cyclooxygenase-2 inhibitor-treated endometrial cancer cells.
Topics: Apoptosis; Biomarkers, Tumor; Blotting, Western; Cell Adhesion; Cell Cycle; Cell Movement; Cell Prol | 2009 |
Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
Topics: Apoptosis; Blotting, Western; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibito | 2004 |
Significant anti-proliferation of human endometrial cancer cells by combined treatment with a selective COX-2 inhibitor NS398 and specific MEK inhibitor U0126.
Topics: Blotting, Western; Butadienes; Cell Proliferation; Cyclooxygenase Inhibitors; Endometrial Neoplasms; | 2005 |